Cite

HARVARD Citation

    Heitmann, J. et al. (n.d.). OC-0275 Safety and efficacy of concurrent SRT and targeted- or immunotherapy for melanoma brain metastases. Radiotherapy and oncology. pp. S136-. [Online]. 
  
Back to record